Causal relationship of COVID-19 on Alzheimer’s disease: an updated Mendelian randomization study
Authors:
Open Access
- 15 April 2023
- journal article
- letter
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (8) , 2643-2644
Abstract
No abstract availableKeywords
Funding Information
- the Department of Science and Technology of Sichuan Province (2020YFS0219, 2021YFS0173)
- 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (Grant No. 21HXFH041)
This publication has 5 references indexed in Scilit:
- COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosisAnnals of Clinical and Translational Neurology, 2022
- Causal effect of COVID‐19 on Alzheimer's disease: A Mendelian randomization studyJournal of Medical Virology, 2022
- Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patientsThe Lancet Psychiatry, 2022
- The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemicEuropean Journal of Human Genetics, 2020
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease riskNature Genetics, 2019